Viewing Study NCT00402558

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-01-24 @ 4:42 AM
Study NCT ID: NCT00402558
Status: COMPLETED
Last Update Posted: 2015-05-08
First Post: 2006-11-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid Leukemia View
None Chronic Myelogenous Leukemia View
None Myelodysplastic Syndrome View
None Leukemia View
None NK Cells View
None Natural Killer Cells View
None Fludarabine View
None Busulfan View
None Thymoglobulin View
None AML View
None CML View
None MDS View
None ATG View
None Antithymocyte globulin View
None Busulfex View
None Myleran® View
None Fludarabine Phosphate View
None G-CSF View
None Filgrastim View
None Neupogen View
None Interleukin-2 View
None IL-2 View
None Aldesleukin View
None Proleukin View
None Tacrolimus View
None Prograf View
None Methotrexate View